Indian Scientists Develop 'Smart' Cancer Drug That Targets Tumour Cells
Published
Scientists in India have developed a new "smart" cancer drug that is designed to become active mainly inside cancer cells. The drug, called RK-251, is meant to attack tumours while leaving healthy cells largely unharmed. This is an important goal in cancer treatment, because many current therapies can also damage normal cells and cause serious side effects for patients.
The main idea behind RK-251 is that it does not work at full strength until it reaches a cancer cell. Once inside the tumour, the drug is activated and begins its work. Researchers hope this targeted approach could reduce the harmful effects that patients often experience during chemotherapy, such as tiredness, hair loss and weakened immunity. The drug is still at an early stage, so more testing will be needed before it can be used in hospitals.
Cancer remains a major health problem in India, where thousands of new cases are reported every year. Experts say that developing home-grown treatments could improve access to advanced care and reduce dependence on expensive imported medicines. However, scientists also stress that laboratory results do not always match results in human patients, so careful clinical trials and approval from regulators will be required before the drug is widely available.
For now, the discovery is seen as a promising step for cancer research in the country. Further studies will show whether RK-251 can be safe and effective for patients. Scientists say they will continue to test the drug and share their findings with the medical community.
Sources: DD News
More India news
- Cheaper Batteries Make Solar and Wind the Lowest-Cost Power Source in India, Says BNEF
- Why Money Flowing Out of India Is Drawing Attention
- Qualcomm Layoffs: What Severance Will Former Employees in India Receive?
- Suriya's Cop Comedy 'Scene' Earns Rs 111 Crore in Five Days at the Box Office
- Ajay Devgn's Drishyam 3: The Conclusion Passes Rs 588 Crore Worldwide After 40 Days
- Ramayana: Part 1 Continues Strong Box Office Run with Rs 440 Crore Collection
- Government Uses Online Marketplace to Buy Farm and Allied Sector Goods
- World Bank Estimates Extreme Poverty in India at 2.6 Per Cent, Sparking Debate